Global Latent Tuberculosis Infection (LTBI) Testing Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Latent Tuberculosis Infection (LTBI) Testing market size is predicted to grow from US$ 1516 million in 2025 to US$ 2102 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
LPI (LP Information)' newest research report, the “Latent Tuberculosis Infection (LTBI) Testing Industry Forecast” looks at past sales and reviews total world Latent Tuberculosis Infection (LTBI) Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Latent Tuberculosis Infection (LTBI) Testing sales for 2025 through 2031. With Latent Tuberculosis Infection (LTBI) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Latent Tuberculosis Infection (LTBI) Testing industry.
This Insight Report provides a comprehensive analysis of the global Latent Tuberculosis Infection (LTBI) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Latent Tuberculosis Infection (LTBI) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Latent Tuberculosis Infection (LTBI) Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Latent Tuberculosis Infection (LTBI) Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Latent Tuberculosis Infection (LTBI) Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Latent Tuberculosis Infection (LTBI) Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Latent Tuberculosis Infection (LTBI) Testing market size is predicted to grow from US$ 1516 million in 2025 to US$ 2102 million in 2031; it is expected to grow at a CAGR of 5.6% from 2025 to 2031.
The Latent Tuberculosis Infection (LTBI) Testing industry can be broken down into several segments, Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA), etc.
Across the world, the major players cover Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis (TB) infection (LTBI) is recognized by the World Health Organization as an important strategy to accelerate the decline in global TB and achieve TB elimination. Latent tuberculosis infection (LTBI) is defined as a state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens without evidence of clinically manifested active tuberculosis (TB). Diagnosis and treatment for LTBI are important for TB, especially in high-risk populations. Tuberculin skin test (TST) and interferon-gamma release assays (IGRAs) are used to diagnose LTBI.
The detection industry of latent tuberculosis infection (LTBI) can be subdivided into several parts: tuberculin skin test (TST), interferon release test (IGRA), etc.
Globally, there are mainly Qiagen, Oxford Immunotec, Sanofi, etc.
Diagnosing and treating latent tuberculosis infection (LTBI) is an important strategy recognized by the World Health Organization to accelerate the decline of global tuberculosis and achieve the elimination of tuberculosis. Latent tuberculosis infection (LTBI) refers to the state of continuous immune response to the stimulation of Mycobacterium tuberculosis antigen in the absence of clinical evidence of active tuberculosis (TB). The diagnosis and treatment of long-term tuberculosis is very important for tuberculosis, especially for high-risk groups. Tuberculin skin tests (TST) and interferon release tests (IGRAs) were used to diagnose LTBI.
LPI (LP Information)' newest research report, the “Latent Tuberculosis Infection (LTBI) Testing Industry Forecast” looks at past sales and reviews total world Latent Tuberculosis Infection (LTBI) Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Latent Tuberculosis Infection (LTBI) Testing sales for 2025 through 2031. With Latent Tuberculosis Infection (LTBI) Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Latent Tuberculosis Infection (LTBI) Testing industry.
This Insight Report provides a comprehensive analysis of the global Latent Tuberculosis Infection (LTBI) Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Latent Tuberculosis Infection (LTBI) Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Latent Tuberculosis Infection (LTBI) Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Latent Tuberculosis Infection (LTBI) Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Latent Tuberculosis Infection (LTBI) Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Latent Tuberculosis Infection (LTBI) Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
- Hospitals and Clinics
- Diagnostic Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Qiagen
- Sanofi
- Oxford Immunotec
- Thermo Fisher Scientific
- Par Sterile
- Bio-Rad Laboratories
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
2.1.2 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Latent Tuberculosis Infection (LTBI) Testing by Country/Region (2020, 2024 & 2031)
2.2 Latent Tuberculosis Infection (LTBI) Testing Segment by Type
2.2.1 Tuberculin Skin Test (TST)
2.2.2 Interferon Gamma Released Assay (IGRA)
2.3 Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
2.3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2020-2025)
2.4 Latent Tuberculosis Infection (LTBI) Testing Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
2.5.1 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2020-2025)
3 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SIZE BY PLAYER
3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Player
3.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Player (2020-2025)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Player (2020-2025)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING BY REGION
4.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2020-2025)
4.4 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2020-2025)
4.5 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
5.2 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
5.3 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025)
6.2 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.3 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing by Region (2020-2025)
8.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET FORECAST
10.1 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2026-2031)
10.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2026-2031)
10.1.2 Americas Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.3 APAC Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.4 Europe Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2 Americas Latent Tuberculosis Infection (LTBI) Testing Forecast by Country (2026-2031)
10.2.1 United States Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2.2 Canada Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2.3 Mexico Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2.4 Brazil Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3 APAC Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2026-2031)
10.3.1 China Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.3.2 Japan Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3.3 Korea Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3.4 Southeast Asia Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3.5 India Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3.6 Australia Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4 Europe Latent Tuberculosis Infection (LTBI) Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4.2 France Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4.3 UK Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4.4 Italy Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4.5 Russia Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.5.2 South Africa Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.5.3 Israel Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.5.4 Turkey Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.6 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Type (2026-2031)
10.7 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Latent Tuberculosis Infection (LTBI) Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Qiagen
11.1.1 Qiagen Company Information
11.1.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Qiagen Main Business Overview
11.1.5 Qiagen Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Oxford Immunotec
11.3.1 Oxford Immunotec Company Information
11.3.2 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Oxford Immunotec Main Business Overview
11.3.5 Oxford Immunotec Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Par Sterile
11.5.1 Par Sterile Company Information
11.5.2 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Par Sterile Main Business Overview
11.5.5 Par Sterile Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. LatentTuberculosis Infection (LTBI)Testing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. LatentTuberculosis Infection (LTBI)Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTuberculin SkinTest (TST)
Table 4. Major Players of Interferon Gamma Released Assay (IGRA)
Table 5. LatentTuberculosis Infection (LTBI)Testing Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 7. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Table 8. LatentTuberculosis Infection (LTBI)Testing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 10. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Table 11. Global LatentTuberculosis Infection (LTBI)Testing Revenue by Player (2020-2025) & ($ millions)
Table 12. Global LatentTuberculosis Infection (LTBI)Testing Revenue Market Share by Player (2020-2025)
Table 13. LatentTuberculosis Infection (LTBI)Testing Key Players Head office and Products Offered
Table 14. LatentTuberculosis Infection (LTBI)Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global LatentTuberculosis Infection (LTBI)Testing Market Size by Region (2020-2025) & ($ millions)
Table 18. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region (2020-2025)
Table 19. Global LatentTuberculosis Infection (LTBI)Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global LatentTuberculosis Infection (LTBI)Testing Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas LatentTuberculosis Infection (LTBI)Testing Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Country (2020-2025)
Table 23. Americas LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 24. Americas LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Table 25. Americas LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Table 27. APAC LatentTuberculosis Infection (LTBI)Testing Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region (2020-2025)
Table 29. APAC LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 30. APAC LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe LatentTuberculosis Infection (LTBI)Testing Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Country (2020-2025)
Table 33. Europe LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 34. Europe LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of LatentTuberculosis Infection (LTBI)Testing
Table 39. Key Market Challenges & Risks of LatentTuberculosis Infection (LTBI)Testing
Table 40. Key IndustryTrends of LatentTuberculosis Infection (LTBI)Testing
Table 41. Global LatentTuberculosis Infection (LTBI)Testing Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global LatentTuberculosis Infection (LTBI)Testing Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global LatentTuberculosis Infection (LTBI)Testing Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Qiagen Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 46. Qiagen LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 47. Qiagen LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Qiagen Main Business
Table 49. Qiagen Latest Developments
Table 50. Sanofi Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 51. Sanofi LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 52. Sanofi LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. Oxford Immunotec Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 56. Oxford Immunotec LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 57. Oxford Immunotec LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Oxford Immunotec Main Business
Table 59. Oxford Immunotec Latest Developments
Table 60.ThermoFisher Scientific Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 61.ThermoFisher Scientific LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 62.ThermoFisher Scientific LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63.ThermoFisher Scientific Main Business
Table 64.ThermoFisher Scientific Latest Developments
Table 65. Par Sterile Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 66. Par Sterile LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 67. Par Sterile LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Par Sterile Main Business
Table 69. Par Sterile Latest Developments
Table 70. Bio-Rad Laboratories Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 71. Bio-Rad Laboratories LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 72. Bio-Rad Laboratories LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Bio-Rad Laboratories Main Business
Table 74. Bio-Rad Laboratories Latest Developments
LIST OFFIGURES
Figure 1. LatentTuberculosis Infection (LTBI)Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global LatentTuberculosis Infection (LTBI)Testing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. LatentTuberculosis Infection (LTBI)Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. LatentTuberculosis Infection (LTBI)Testing Sales Market Share by Country/Region (2024)
Figure 8. LatentTuberculosis Infection (LTBI)Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType in 2024
Figure 10. LatentTuberculosis Infection (LTBI)Testing in Hospitals and Clinics
Figure 11. Global LatentTuberculosis Infection (LTBI)Testing Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. LatentTuberculosis Infection (LTBI)Testing in Diagnostic Laboratories
Figure 13. Global LatentTuberculosis Infection (LTBI)Testing Market: Diagnostic Laboratories (2020-2025) & ($ millions)
Figure 14. LatentTuberculosis Infection (LTBI)Testing in Others
Figure 15. Global LatentTuberculosis Infection (LTBI)Testing Market: Others (2020-2025) & ($ millions)
Figure 16. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application in 2024
Figure 17. Global LatentTuberculosis Infection (LTBI)Testing Revenue Market Share by Player in 2024
Figure 18. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region (2020-2025)
Figure 19. Americas LatentTuberculosis Infection (LTBI)Testing Market Size 2020-2025 ($ millions)
Figure 20. APAC LatentTuberculosis Infection (LTBI)Testing Market Size 2020-2025 ($ millions)
Figure 21. Europe LatentTuberculosis Infection (LTBI)Testing Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size 2020-2025 ($ millions)
Figure 23. Americas LatentTuberculosis Infection (LTBI)Testing Value Market Share by Country in 2024
Figure 24. United States LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region in 2024
Figure 29. APAC LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Figure 30. APAC LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Figure 31. China LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 35. India LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Country in 2024
Figure 38. Europe LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Figure 39. Europe LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Figure 40. Germany LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 41.France LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 42. UK LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Figure 48. Egypt LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 54. APAC LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 55. Europe LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 57. United States LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 58. Canada LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 59. Mexico LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 60. Brazil LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 61. China LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 62. Japan LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 63. Korea LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 65. India LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 66. Australia LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 67. Germany LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 68.France LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 69. UK LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 70. Italy LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 71. Russia LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 72. Egypt LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 73. South Africa LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 74. Israel LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 75.Turkey LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 76. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size (2020-2031)
2.1.2 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Latent Tuberculosis Infection (LTBI) Testing by Country/Region (2020, 2024 & 2031)
2.2 Latent Tuberculosis Infection (LTBI) Testing Segment by Type
2.2.1 Tuberculin Skin Test (TST)
2.2.2 Interferon Gamma Released Assay (IGRA)
2.3 Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
2.3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2020-2025)
2.4 Latent Tuberculosis Infection (LTBI) Testing Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
2.5.1 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2020-2025)
3 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET SIZE BY PLAYER
3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Player
3.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Player (2020-2025)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Player (2020-2025)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LATENT TUBERCULOSIS INFECTION (LTBI) TESTING BY REGION
4.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025)
4.2 Global Latent Tuberculosis Infection (LTBI) Testing Annual Revenue by Country/Region (2020-2025)
4.3 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2020-2025)
4.4 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2020-2025)
4.5 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2020-2025)
4.6 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
5.2 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
5.3 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2020-2025)
6.2 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
6.3 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2020-2025)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing by Region (2020-2025)
8.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2020-2025)
8.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LATENT TUBERCULOSIS INFECTION (LTBI) TESTING MARKET FORECAST
10.1 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2026-2031)
10.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2026-2031)
10.1.2 Americas Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.3 APAC Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.4 Europe Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2 Americas Latent Tuberculosis Infection (LTBI) Testing Forecast by Country (2026-2031)
10.2.1 United States Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2.2 Canada Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2.3 Mexico Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2.4 Brazil Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3 APAC Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2026-2031)
10.3.1 China Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.3.2 Japan Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3.3 Korea Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3.4 Southeast Asia Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3.5 India Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.3.6 Australia Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4 Europe Latent Tuberculosis Infection (LTBI) Testing Forecast by Country (2026-2031)
10.4.1 Germany Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4.2 France Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4.3 UK Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4.4 Italy Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.4.5 Russia Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2026-2031)
10.5.1 Egypt Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.5.2 South Africa Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.5.3 Israel Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.5.4 Turkey Market Latent Tuberculosis Infection (LTBI) Testing Forecast
10.6 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Type (2026-2031)
10.7 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Latent Tuberculosis Infection (LTBI) Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Qiagen
11.1.1 Qiagen Company Information
11.1.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Qiagen Main Business Overview
11.1.5 Qiagen Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Oxford Immunotec
11.3.1 Oxford Immunotec Company Information
11.3.2 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Oxford Immunotec Main Business Overview
11.3.5 Oxford Immunotec Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Par Sterile
11.5.1 Par Sterile Company Information
11.5.2 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Par Sterile Main Business Overview
11.5.5 Par Sterile Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. LatentTuberculosis Infection (LTBI)Testing Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. LatentTuberculosis Infection (LTBI)Testing Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofTuberculin SkinTest (TST)
Table 4. Major Players of Interferon Gamma Released Assay (IGRA)
Table 5. LatentTuberculosis Infection (LTBI)Testing Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 7. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Table 8. LatentTuberculosis Infection (LTBI)Testing Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 10. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Table 11. Global LatentTuberculosis Infection (LTBI)Testing Revenue by Player (2020-2025) & ($ millions)
Table 12. Global LatentTuberculosis Infection (LTBI)Testing Revenue Market Share by Player (2020-2025)
Table 13. LatentTuberculosis Infection (LTBI)Testing Key Players Head office and Products Offered
Table 14. LatentTuberculosis Infection (LTBI)Testing Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global LatentTuberculosis Infection (LTBI)Testing Market Size by Region (2020-2025) & ($ millions)
Table 18. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region (2020-2025)
Table 19. Global LatentTuberculosis Infection (LTBI)Testing Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global LatentTuberculosis Infection (LTBI)Testing Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas LatentTuberculosis Infection (LTBI)Testing Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Country (2020-2025)
Table 23. Americas LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 24. Americas LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Table 25. Americas LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Table 27. APAC LatentTuberculosis Infection (LTBI)Testing Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region (2020-2025)
Table 29. APAC LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 30. APAC LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe LatentTuberculosis Infection (LTBI)Testing Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Country (2020-2025)
Table 33. Europe LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 34. Europe LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of LatentTuberculosis Infection (LTBI)Testing
Table 39. Key Market Challenges & Risks of LatentTuberculosis Infection (LTBI)Testing
Table 40. Key IndustryTrends of LatentTuberculosis Infection (LTBI)Testing
Table 41. Global LatentTuberculosis Infection (LTBI)Testing Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global LatentTuberculosis Infection (LTBI)Testing Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global LatentTuberculosis Infection (LTBI)Testing Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Qiagen Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 46. Qiagen LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 47. Qiagen LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Qiagen Main Business
Table 49. Qiagen Latest Developments
Table 50. Sanofi Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 51. Sanofi LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 52. Sanofi LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Sanofi Main Business
Table 54. Sanofi Latest Developments
Table 55. Oxford Immunotec Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 56. Oxford Immunotec LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 57. Oxford Immunotec LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Oxford Immunotec Main Business
Table 59. Oxford Immunotec Latest Developments
Table 60.ThermoFisher Scientific Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 61.ThermoFisher Scientific LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 62.ThermoFisher Scientific LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63.ThermoFisher Scientific Main Business
Table 64.ThermoFisher Scientific Latest Developments
Table 65. Par Sterile Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 66. Par Sterile LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 67. Par Sterile LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Par Sterile Main Business
Table 69. Par Sterile Latest Developments
Table 70. Bio-Rad Laboratories Details, CompanyType, LatentTuberculosis Infection (LTBI)Testing Area Served and Its Competitors
Table 71. Bio-Rad Laboratories LatentTuberculosis Infection (LTBI)Testing Product Offered
Table 72. Bio-Rad Laboratories LatentTuberculosis Infection (LTBI)Testing Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Bio-Rad Laboratories Main Business
Table 74. Bio-Rad Laboratories Latest Developments
LIST OFFIGURES
Figure 1. LatentTuberculosis Infection (LTBI)Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global LatentTuberculosis Infection (LTBI)Testing Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. LatentTuberculosis Infection (LTBI)Testing Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. LatentTuberculosis Infection (LTBI)Testing Sales Market Share by Country/Region (2024)
Figure 8. LatentTuberculosis Infection (LTBI)Testing Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType in 2024
Figure 10. LatentTuberculosis Infection (LTBI)Testing in Hospitals and Clinics
Figure 11. Global LatentTuberculosis Infection (LTBI)Testing Market: Hospitals and Clinics (2020-2025) & ($ millions)
Figure 12. LatentTuberculosis Infection (LTBI)Testing in Diagnostic Laboratories
Figure 13. Global LatentTuberculosis Infection (LTBI)Testing Market: Diagnostic Laboratories (2020-2025) & ($ millions)
Figure 14. LatentTuberculosis Infection (LTBI)Testing in Others
Figure 15. Global LatentTuberculosis Infection (LTBI)Testing Market: Others (2020-2025) & ($ millions)
Figure 16. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application in 2024
Figure 17. Global LatentTuberculosis Infection (LTBI)Testing Revenue Market Share by Player in 2024
Figure 18. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region (2020-2025)
Figure 19. Americas LatentTuberculosis Infection (LTBI)Testing Market Size 2020-2025 ($ millions)
Figure 20. APAC LatentTuberculosis Infection (LTBI)Testing Market Size 2020-2025 ($ millions)
Figure 21. Europe LatentTuberculosis Infection (LTBI)Testing Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size 2020-2025 ($ millions)
Figure 23. Americas LatentTuberculosis Infection (LTBI)Testing Value Market Share by Country in 2024
Figure 24. United States LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region in 2024
Figure 29. APAC LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Figure 30. APAC LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Figure 31. China LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 35. India LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Country in 2024
Figure 38. Europe LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Figure 39. Europe LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Figure 40. Germany LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 41.France LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 42. UK LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size Market Share by Application (2020-2025)
Figure 48. Egypt LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries LatentTuberculosis Infection (LTBI)Testing Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 54. APAC LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 55. Europe LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 57. United States LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 58. Canada LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 59. Mexico LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 60. Brazil LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 61. China LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 62. Japan LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 63. Korea LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 65. India LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 66. Australia LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 67. Germany LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 68.France LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 69. UK LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 70. Italy LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 71. Russia LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 72. Egypt LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 73. South Africa LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 74. Israel LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 75.Turkey LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
Figure 76. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global LatentTuberculosis Infection (LTBI)Testing Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries LatentTuberculosis Infection (LTBI)Testing Market Size 2026-2031 ($ millions)
More Publications
Global Latent Tuberculosis Infection (LTBI) Testing Market Report: Insights, Trends & Forecast (2019-2023)
US$ 1,700.00
July 2019
106 pages
Global Meningococcal Infections Vaccine Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
77 pages
Global Gram-positive Bacterial Infection Drugs Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
100 pages
